Report cover image

Immunoassay Market Size, Share, Trends, Industry Analysis Report: By Products (Reagents & Kits, Analyzers/Instruments, and Software & Services), Technology, Specimen, Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America,

Publisher Polaris Market Research & Consulting LLP
Published Apr 01, 2025
Length 209 Pages
SKU # PLRS20077002

Description

The global immunoassay market size is expected to reach USD 50.95 billion by 2034, according to a new study by Polaris Market Research. The report “Immunoassay Market Size, Share, Trends, Industry Analysis Report: By Products (Reagents & Kits, Analyzers/Instruments, and Software & Services), Technology, Specimen, Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The immunoassay market growth is driven by increasing demand for precise diagnostic tools and advancements in technology. Immunoassays are primarily used to detect specific biomarkers such as proteins, lipids, and nucleic acids in biological samples and have become essential in clinical diagnostics, pharmaceutical research, and scientific investigations. The market is expanding rapidly, with key players leveraging innovations in assay platforms, multiplex testing, and automation to enhance diagnostic accuracy and efficiency. Furthermore, with the growing demand for faster, more accurate disease detection methods, the market is expected to witness significant growth opportunities during the forecast period.

The expanding healthcare infrastructure in emerging economies, which is improving access to advanced diagnostic solutions, is fueling the immunoassay market development. Additionally, the rising prevalence of chronic and infectious diseases, along with advancements in healthcare technology, is significantly boosting market demand. The increasing focus on preventive healthcare and the growing adoption of immunoassays in routine diagnostic practices are further creating immunoassay market opportunities.

The immunoassay market faces challenges, particularly due to stringent regulations associated with product development and validation. Regulatory bodies require extensive clinical testing and validation before the commercialization of products, which ultimately increases the development costs. Furthermore, the complexity of regulatory requirements varies by region, which complicates the entry of new products into international markets. These factors create barriers to innovation and increase the operational challenges for companies aiming to expand their market presence.

Immunoassay Market Report Highlights

In terms of products, the reagents & kits segment accounted for the largest immunoassay market share in 2024 due to their essential role in diagnostic testing, widespread usage in laboratories, and consistent demand for high-quality, accurate results.

Based on specimen type, the blood segment is expected to witness the fastest growth rate due to its high relevance in disease diagnosis, ease of collection, and ability to detect a wide range of biomarkers.

In 2024, North America accounted for the largest share of the global immunoassay market revenue, driven by advanced healthcare infrastructure, high demand for diagnostic tools, and significant investments in research and technology.

The Asia Pacific market is expected to witness the fastest growth during the forecast period due to rising healthcare awareness, expanding diagnostic capabilities, and growing demand for advanced medical technologies in the region.

A few of the global key market players are Abbott; BD; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; BIOMÉRIEUX; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Siemens Healthineers AG; QuidelOrtho Corporation; and Sysmex Corporation.

Polaris Market Research has segmented the immunoassay market report on the basis of products, technology, specimen, applications, end users, and region:

By Products Outlook (Revenue, USD Billion, 2021–2034)

Reagents & Kits

ELISA Reagents & Kits

Rapid Test Reagents & Kits

ELISPOT Reagents & Kits

Western Blot Reagents & Kits

Other Reagents & Kits

Analyzers/Instruments

Open Ended Systems

Closed Ended Systems

Software & Services

By Technology Outlook (Revenue, USD Billion, 2021–2034)

Radioimmunoassay (RIA)

Enzyme Immunoassays (EIA)

Chemiluminescence Immunoassays (CLIA)

Fluorescence Immunoassays (FIA)

Rapid Tests

Others

By Specimen Outlook (Revenue, USD Billion, 2021–2034)

Blood

Saliva

Urine

Others

By Application Outlook (Revenue, USD Billion, 2021–2034)

Therapeutic Drug Monitoring

Oncology

Cardiology

Endocrinology

Infectious Disease Testing

Autoimmune Diseases

Others

By End Users Outlook (Revenue, USD Billion, 2021–2034)

Hospitals

Laboratories

Others

By Regional Outlook (Revenue, USD Billion, 2021–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

209 Pages
Chapter 1. Introduction
1.1 Report Description
1.1.1 Objective of the Study
1.1.2 Market Scope
1.1.3 Assumptions
1.2 Stakeholders
Chapter 2. Research Methodology
2.1 Research Methodology
2.2 Research Scope and Assumptions
2.3 Information Procurement
2.3.1 Purchased Database
2.3.2 Internal Database
2.3.3 Secondary Sources
2.3.4 Third Party Perspective
2.3.5 Primary Research
2.4 Information Analysis
2.4.1 Data Analysis Models
2.5 Market Formulation and Data Visualization
2.6 Data Validation and Publishing (Secondary Sources)
Chapter 3. Executive Summary
Chapter 4. Market Insights
4.1 Immunoassay – Industry Snapshot
4.2 Immunoassay Market - Value Chain Analysis
4.2.1 Immunoassay Market Dynamics
4.2.2 Drivers and Opportunities
4.2.2.1 Growing Prevalence of Chronic Diseases Globally
4.2.2.2 Expanding Healthcare Infrastructure in Emerging Economies
4.2.3 Restraints and Challenges
4.2.3.1 Stringent Regulation in Product Development and Validation
4.3 Immunoassay Market – Porter’s Five Forces
4.3.1 Threat of Substitutes (Low to Moderate)
4.3.2 Threat of New Entrants (Moderate)
4.3.3 Bargaining Power of Buyers (Moderate to High)
4.3.4 Bargaining Power of Suppliers (Moderate)
4.3.5 Competitive Rivalry (High)
4.4 Immunoassay Market – PESTLE Analysis
Chapter 5. Immunoassay Market Assessment by Product
5.1 Introduction
5.2 Reagents & Kits
5.2.1 ELISA Reagents & Kits
5.2.2 Rapid Test Reagents & Kits
5.2.3 Western Blot Reagents & Kits
5.2.4 ELISPOT Reagents & Kits
5.2.5 Other Reagents & Kits
5.3 Analyzers/Instruments
5.3.1 Open Ended Systems
5.3.2 Closed Ended Systems
5.4 Software & Services
Chapter 6. Immunoassay Market Assessment by Technology
6.1 Introduction
6.2 Enzyme Immunoassays (EIA)
6.2.1 Chemiluminescence Immunoassays (CLIA)
6.2.2 Fluorescence Immunoassays (FIA)
6.3 Rapid Test
6.4 Radioimmunoassay (RIA)
6.5 Others
Chapter 7. Immunoassay Market Assessment by Specimen
7.1 Introduction
7.2 Blood
7.3 Urine
7.4 Saliva
7.5 Others
Chapter 8. Immunoassay Market Assessment by Application
8.1 Introduction
8.2 Infectious Disease Testing
8.3 Cardiology
8.4 Oncology
8.5 Endocrinology
8.6 Autoimmune Diseases
8.7 Therapeutic Drug Monitoring
8.8 Others
Chapter 9. Immunoassay Market Assessment by End Use
9.1 Introduction
9.2 Hospitals
9.3 Laboratories
9.4 Others
Chapter 10. Immunoassay Market Assessment by Region
10.1 Introduction
10.2 Immunoassay Market – North America
10.2.1 North America Immunoassay, Product
10.2.1.1 North America Immunoassay, Reagents & Kits
10.2.1.2 North America Immunoassay, Analyzers/Instruments
10.2.2 North America Immunoassay, Technology
10.2.2.1 North America Immunoassay, Enzyme Immunoassays (EIA)
10.2.3 North America Immunoassay, Specimen
10.2.4 North America Immunoassay, Application
10.2.5 North America Immunoassay, End Use
10.2.6 Immunoassay Market – US
10.2.6.1 US Immunoassay, Product
10.2.6.1.1 US Immunoassay, Reagents & Kits
10.2.6.1.2 US Immunoassay, Analyzers/Instruments
10.2.6.2 US Immunoassay, Technology
10.2.6.2.1 US Immunoassay, Enzyme Immunoassays (EIA)
10.2.6.3 US Immunoassay, Specimen
10.2.6.4 US Immunoassay, Application
10.2.6.5 US Immunoassay, End Use
10.2.7 Immunoassay Market – Canada
10.2.7.1 Canada Immunoassay, Product
10.2.7.1.1 Canada Immunoassay, Reagents & Kits
10.2.7.1.2 Canada Immunoassay, Analyzers/Instruments
10.2.7.2 Canada Immunoassay, Technology
10.2.7.2.1 Canada Immunoassay, Enzyme Immunoassays (EIA)
10.2.7.3 Canada Immunoassay, Specimen
10.2.7.4 Canada Immunoassay, Application
10.2.7.5 Canada Immunoassay, End Use
10.3 Immunoassay Market – Europe
10.3.1 Europe Immunoassay, Product
10.3.1.1 Europe Immunoassay, Reagents & Kits
10.3.1.2 Europe Immunoassay, Analyzers/Instruments
10.3.2 Europe Immunoassay, Technology
10.3.2.1 Europe Immunoassay Market, Enzyme Immunoassays (EIA)
10.3.3 Europe Immunoassay, Specimen
10.3.4 Europe Immunoassay, Application
10.3.5 Europe Immunoassay, End Use
10.3.6 Immunoassay Market – UK
10.3.6.1 UK Immunoassay, Product
10.3.6.1.1 UK Immunoassay, Reagents & Kits
10.3.6.1.2 UK Immunoassay, Analyzers/Instruments
10.3.6.2 UK Immunoassay, Technology
10.3.6.2.1 UK Immunoassay, Enzyme Immunoassays (EIA)
10.3.6.3 UK Immunoassay, Specimen
10.3.6.4 UK Immunoassay, Application
10.3.6.5 UK Immunoassay, End Use
10.3.7 Immunoassay Market – France
10.3.7.1 France Immunoassay, Product
10.3.7.1.1 France Immunoassay, Reagents & Kits
10.3.7.1.2 France Immunoassay, Analyzers/Instruments
10.3.7.2 France Immunoassay, Technology
10.3.7.2.1 France Immunoassay, Enzyme Immunoassays (EIA)
10.3.7.3 France Immunoassay, Specimen
10.3.7.4 France Immunoassay, Application
10.3.7.5 France Immunoassay, End Use
10.3.8 Immunoassay Market – Germany
10.3.8.1 Germany Immunoassay, Product
10.3.8.1.1 Germany Immunoassay, Reagents & Kits
10.3.8.1.2 Germany Immunoassay, Analyzers/Instruments
10.3.8.2 Germany Immunoassay, Technology
10.3.8.2.1 Germany Immunoassay, Enzyme Immunoassays (EIA)
10.3.8.3 Germany Immunoassay, Specimen
10.3.8.4 Germany Immunoassay, Application
10.3.8.5 Germany Immunoassay, End Use
10.3.9 Immunoassay Market – Italy
10.3.9.1 Italy Immunoassay, Product
10.3.9.1.1 Italy Immunoassay, Reagents & Kits
10.3.9.1.2 Italy Immunoassay, Analyzers/Instruments
10.3.9.2 Italy Immunoassay, Technology
10.3.9.2.1 Italy Immunoassay, Enzyme Immunoassays (EIA)
10.3.9.3 Italy Immunoassay, Specimen
10.3.9.4 Italy Immunoassay, Application
10.3.9.5 Italy Immunoassay, End Use
10.3.10 Immunoassay Market – Spain
10.3.10.1 Spain Immunoassay, Product
10.3.10.1.1 Spain Immunoassay, Reagents & Kits
10.3.10.1.2 Spain Immunoassay, Analyzers/Instruments
10.3.10.2 Spain Immunoassay, Technology
10.3.10.2.1 Spain Immunoassay, Enzyme Immunoassays (EIA)
10.3.10.3 Spain Immunoassay, Specimen
10.3.10.4 Spain Immunoassay, Application
10.3.10.5 Spain Immunoassay, End Use
10.3.11 Immunoassay Market – Netherlands
10.3.11.1 Netherlands Immunoassay, Product
10.3.11.1.1 Netherlands Immunoassay, Reagents & Kits
10.3.11.1.2 Netherlands Immunoassay, Analyzers/Instruments
10.3.11.2 Netherlands Immunoassay, Technology
10.3.11.2.1 Netherlands Immunoassay, Enzyme Immunoassays (EIA)
10.3.11.3 Netherlands Immunoassay, Specimen
10.3.11.4 Netherlands Immunoassay, Application
10.3.11.5 Netherlands Immunoassay, End Use
10.3.12 Immunoassay Market – Russia
10.3.12.1 Russia Immunoassay, Product
10.3.12.1.1 Russia Immunoassay, Reagents & Kits
10.3.12.1.2 Russia Immunoassay, Analyzers/Instruments
10.3.12.2 Russia Immunoassay, Technology
10.3.12.2.1 Russia Immunoassay, Enzyme Immunoassays (EIA)
10.3.12.3 Russia Immunoassay, Specimen
10.3.12.4 Russia Immunoassay, Application
10.3.12.5 Russia Immunoassay, End Use
10.3.13 Immunoassay Market – Rest of Europe
10.3.13.1 Rest of Europe Immunoassay, Product
10.3.13.1.1 Rest of Europe Immunoassay, Reagents & Kits
10.3.13.1.2 Rest of Europe Immunoassay, Analyzers/Instruments
10.3.13.2 Rest of Europe Immunoassay, Technology
10.3.13.2.1 Rest of Europe Immunoassay, Enzyme Immunoassays (EIA)
10.3.13.3 Rest of Europe Immunoassay, Specimen
10.3.13.4 Rest of Europe Immunoassay, Application
10.3.13.5 Rest of Europe Immunoassay, End Use
10.4 Immunoassay Market – Asia Pacific
10.4.1 Asia Pacific Immunoassay, Product
10.4.1.1 Asia Pacific Immunoassay, Reagents & Kits
10.4.1.2 Asia Pacific Immunoassay, Analyzers/Instruments
10.4.2 Asia Pacific Immunoassay, Technology
10.4.2.1 Asia Pacific Immunoassay Market, Enzyme Immunoassays (EIA)
10.4.3 Asia Pacific Immunoassay, Specimen
10.4.4 Asia Pacific Immunoassay, Application
10.4.5 Asia Pacific Immunoassay, End Use
10.4.6 Immunoassay Market – China
10.4.6.1 China Immunoassay, Product
10.4.6.1.1 China Immunoassay, Reagents & Kits
10.4.6.1.2 China Immunoassay, Analyzers/Instruments
10.4.6.2 China Immunoassay, Technology
10.4.6.2.1 China Immunoassay, Enzyme Immunoassays (EIA)
10.4.6.3 China Immunoassay, Specimen
10.4.6.4 China Immunoassay, Application
10.4.6.5 China Immunoassay, End Use
10.4.7 Immunoassay Market – Japan
10.4.7.1 Japan Immunoassay, Product
10.4.7.1.1 Japan Immunoassay, Reagents & Kits
10.4.7.1.2 Japan Immunoassay, Analyzers/Instruments
10.4.7.2 Japan Immunoassay, Technology
10.4.7.2.1 Japan Immunoassay, Enzyme Immunoassays (EIA)
10.4.7.3 Japan Immunoassay, Specimen
10.4.7.4 Japan Immunoassay, Application
10.4.7.5 Japan Immunoassay, End Use
10.4.8 Immunoassay Market – South Korea
10.4.8.1 South Korea Immunoassay, Product
10.4.8.1.1 South Korea Immunoassay, Reagents & Kits
10.4.8.1.2 South Korea Immunoassay, Analyzers/Instruments
10.4.8.2 South Korea Immunoassay, Technology
10.4.8.2.1 South Korea Immunoassay, Enzyme Immunoassays (EIA)
10.4.8.3 South Korea Immunoassay, Specimen
10.4.8.4 South Korea Immunoassay, Application
10.4.8.5 South Korea Immunoassay, End Use
10.4.9 Immunoassay Market – India
10.4.9.1 India Immunoassay, Product
10.4.9.1.1 India Immunoassay, Reagents & Kits
10.4.9.1.2 India Immunoassay, Analyzers/Instruments
10.4.9.2 India Immunoassay, Technology
10.4.9.2.1 India Immunoassay, Enzyme Immunoassays (EIA)
10.4.9.3 India Immunoassay, Specimen
10.4.9.4 India Immunoassay, Application
10.4.9.5 India Immunoassay, End Use
10.4.10 Immunoassay Market – Malaysia
10.4.10.1 Malaysia Immunoassay, Product
10.4.10.1.1 Malaysia Immunoassay, Reagents & Kits
10.4.10.1.2 Malaysia Immunoassay, Analyzers/Instruments
10.4.10.2 Malaysia Immunoassay, Technology
10.4.10.2.1 Malaysia Immunoassay, Enzyme Immunoassays (EIA)
10.4.10.3 Malaysia Immunoassay, Specimen
10.4.10.4 Malaysia Immunoassay, Application
10.4.10.5 Malaysia Immunoassay, End Use
10.4.11 Immunoassay Market – Australia
10.4.11.1 Australia Immunoassay, Product
10.4.11.1.1 Australia Immunoassay, Reagents & Kits
10.4.11.1.2 Australia Immunoassay, Analyzers/Instruments
10.4.11.2 Australia Immunoassay, Technology
10.4.11.2.1 Australia Immunoassay, Enzyme Immunoassays (EIA)
10.4.11.3 Australia Immunoassay, Specimen
10.4.11.4 Australia Immunoassay, Application
10.4.11.5 Australia Immunoassay, End Use
10.4.12 Immunoassay Market – Indonesia
10.4.12.1 Indonesia Immunoassay, Product
10.4.12.1.1 Indonesia Immunoassay, Reagents & Kits
10.4.12.1.2 Indonesia Immunoassay, Analyzers/Instruments
10.4.12.2 Indonesia Immunoassay, Technology
10.4.12.2.1 Indonesia Immunoassay, Enzyme Immunoassays (EIA)
10.4.12.3 Indonesia Immunoassay, Specimen
10.4.12.4 Indonesia Immunoassay, Application
10.4.12.5 Indonesia Immunoassay, End Use
10.4.13 Immunoassay Market – Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Immunoassay, Product
10.4.13.1.1 Rest of Asia Pacific Immunoassay, Reagents & Kits
10.4.13.1.2 Rest of Asia Pacific Immunoassay, Analyzers/Instruments
10.4.13.2 Rest of Asia Pacific Immunoassay, Technology
10.4.13.2.1 Rest of Asia Pacific Immunoassay, Enzyme Immunoassays (EIA)
10.4.13.3 Rest of Asia Pacific Immunoassay, Specimen
10.4.13.4 Rest of Asia Pacific Immunoassay, Application
10.4.13.5 Rest of Asia Pacific Immunoassay, End Use
10.5 Immunoassay Market – Latin America
10.5.1 Latin America Immunoassay, Product
10.5.1.1 Latin America Immunoassay, Reagents & Kits
10.5.1.2 Latin America Immunoassay, Analyzers/Instruments
10.5.2 Latin America Immunoassay, Technology
10.5.2.1 Latin America Immunoassay Market, Enzyme Immunoassays (EIA)
10.5.3 Latin America Immunoassay, Specimen
10.5.4 Latin America Immunoassay, Application
10.5.5 Latin America Immunoassay, End Use
10.5.6 Immunoassay Market – Brazil
10.5.6.1 Brazil Immunoassay, Product
10.5.6.1.1 Brazil Immunoassay, Reagents & Kits
10.5.6.1.2 Brazil Immunoassay, Analyzers/Instruments
10.5.6.2 Brazil Immunoassay, Technology
10.5.6.2.1 Brazil Immunoassay, Enzyme Immunoassays (EIA)
10.5.6.3 Brazil Immunoassay, Specimen
10.5.6.4 Brazil Immunoassay, Application
10.5.6.5 Brazil Immunoassay, End Use
10.5.7 Immunoassay Market – Mexico
10.5.7.1 Mexico Immunoassay, Product
10.5.7.1.1 Mexico Immunoassay, Reagents & Kits
10.5.7.1.2 Mexico Immunoassay, Analyzers/Instruments
10.5.7.2 Mexico Immunoassay, Technology
10.5.7.2.1 Mexico Immunoassay, Enzyme Immunoassays (EIA)
10.5.7.3 Mexico Immunoassay, Specimen
10.5.7.4 Mexico Immunoassay, Application
10.5.7.5 Mexico Immunoassay, End Use
10.5.8 Immunoassay Market – Argentina
10.5.8.1 Argentina Immunoassay, Product
10.5.8.1.1 Argentina Immunoassay, Reagents & Kits
10.5.8.1.2 Argentina Immunoassay, Analyzers/Instruments
10.5.8.2 Argentina Immunoassay, Technology
10.5.8.2.1 Argentina Immunoassay, Enzyme Immunoassays (EIA)
10.5.8.3 Argentina Immunoassay, Specimen
10.5.8.4 Argentina Immunoassay, Application
10.5.8.5 Argentina Immunoassay, End Use
10.5.9 Immunoassay Market – Rest of Latin America
10.5.9.1 Rest of Latin America Immunoassay, Product
10.5.9.1.1 Rest of Latin America Immunoassay, Reagents & Kits
10.5.9.1.2 Rest of Latin America Immunoassay, Analyzers/Instruments
10.5.9.2 Rest of Latin America Immunoassay, Technology
10.5.9.2.1 Rest of Latin America Immunoassay, Enzyme Immunoassays (EIA)
10.5.9.3 Rest of Latin America Immunoassay, Specimen
10.5.9.4 Rest of Latin America Immunoassay, Application
10.5.9.5 Rest of Latin America Immunoassay, End Use
10.6 Immunoassay Market – Middle East and Africa
10.6.1 Middle East and Africa Immunoassay, Product
10.6.1.1 Middle East and Africa Immunoassay, Reagents & Kits
10.6.1.2 Middle East and Africa Immunoassay, Analyzers/Instruments
10.6.2 Middle East and Africa Immunoassay, Technology
10.6.2.1 Middle East and Africa Immunoassay Market, Enzyme Immunoassays (EIA)
10.6.3 Middle East and Africa Immunoassay, Specimen
10.6.4 Middle East and Africa Immunoassay, Application
10.6.5 Middle East and Africa Immunoassay, End Use
10.6.6 Immunoassay Market – UAE
10.6.6.1 UAE Immunoassay, Product
10.6.6.1.1 UAE Immunoassay, Reagents & Kits
10.6.6.1.2 UAE Immunoassay, Analyzers/Instruments
10.6.6.2 UAE Immunoassay, Technology
10.6.6.2.1 UAE Immunoassay, Enzyme Immunoassays (EIA)
10.6.6.3 UAE Immunoassay, Specimen
10.6.6.4 UAE Immunoassay, Application
10.6.6.5 UAE Immunoassay, End Use
10.6.7 Immunoassay Market – Israel
10.6.7.1 Israel Immunoassay, Product
10.6.7.1.1 Israel Immunoassay, Reagents & Kits
10.6.7.1.2 Israel Immunoassay, Analyzers/Instruments
10.6.7.2 Israel Immunoassay, Technology
10.6.7.2.1 Israel Immunoassay, Enzyme Immunoassays (EIA)
10.6.7.3 Israel Immunoassay, Specimen
10.6.7.4 Israel Immunoassay, Application
10.6.7.5 Israel Immunoassay, End Use
10.6.8 Immunoassay Market – Saudi Arabia
10.6.8.1 Saudi Arabia Immunoassay, Product
10.6.8.1.1 Saudi Arabia Immunoassay, Reagents & Kits
10.6.8.1.2 Saudi Arabia Immunoassay, Analyzers/Instruments
10.6.8.2 Saudi Arabia Immunoassay, Technology
10.6.8.2.1 Saudi Arabia Immunoassay, Enzyme Immunoassays (EIA)
10.6.8.3 Saudi Arabia Immunoassay, Specimen
10.6.8.4 Saudi Arabia Immunoassay, Application
10.6.8.5 Saudi Arabia Immunoassay, End Use
10.6.9 Immunoassay Market – South Africa
10.6.9.1 South Africa Immunoassay, Product
10.6.9.1.1 South Africa Immunoassay, Reagents & Kits
10.6.9.1.2 South Africa Immunoassay, Analyzers/Instruments
10.6.9.2 South Africa Immunoassay, Technology
10.6.9.2.1 South Africa Immunoassay, Enzyme Immunoassays (EIA)
10.6.9.3 South Africa Immunoassay, Specimen
10.6.9.4 South Africa Immunoassay, Application
10.6.9.5 South Africa Immunoassay, End Use
10.6.10 Immunoassay Market – Rest of Middle East & Africa
10.6.10.1 Rest of Middle East & Africa Immunoassay, Product
10.6.10.1.1 Rest of Middle East & Africa Immunoassay, Reagents & Kits
10.6.10.1.2 Rest of Middle East & Africa Immunoassay, Analyzers/Instruments
10.6.10.2 Rest of Middle East & Africa Immunoassay, Technology
10.6.10.2.1 Rest of Middle East & Africa Immunoassay, Enzyme Immunoassays (EIA)
10.6.10.3 Rest of Middle East & Africa Immunoassay, Specimen
10.6.10.4 Rest of Middle East & Africa Immunoassay, Application
10.6.10.5 Rest of Middle East & Africa Immunoassay, End Use
Chapter 11. Competitive Landscape
11.1 Key Market Players: Categorization
11.2 Strategy Framework
11.3 Vendor Landscape
11.4 Strategies Categorization
11.4.1 Product Launch/ Product Development
11.4.2 Partnership/Acquisition/Collaboration
Chapter 12. Company Profiles
12.1 Abbott
12.1.1 Business Overview
12.1.2 Financial Snapshot
12.1.2.1 Net Sales by Market Segment
12.1.3 Products and Services
12.2 BD
12.2.1 Business Overview
12.2.2 Financial Snapshot
12.2.2.1 Revenue by Market Segment
12.2.2.2 Revenue by Region
12.2.3 Products and Services
12.3 Beckman Coulter, Inc.
12.3.1 Business Overview
12.3.2 Products and Services
12.3.3 Recent Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Business Overview
12.4.2 Financial Snapshot
12.4.2.1 Net Sales by Segment
12.4.2.2 Net Sales by Region
12.4.3 Products and Services
12.4.4 Recent Developments
12.5 BIOMÉRIEUX
12.5.1 Business Overview
12.5.2 Financial Snapshot
12.5.2.1 Revenue by Segment
12.5.2.2 Revenue by Region
12.5.3 Products and Services
12.5.4 Recent Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Business Overview
12.6.2 Financial Snapshot
12.6.2.1 Sales by Market Segment
12.6.2.2 Sales by Region
12.6.3 Products and Services
12.6.4 Recent Developments
12.7 Thermo Fisher Scientific Inc.
12.7.1 Business Overview
12.7.2 Financial Snapshot
12.7.2.1 Revenue by Segment
12.7.2.2 Revenue by Region
12.7.3 Products and Services
12.7.4 Recent Developments
12.8 Siemens Healthineers AG
12.8.1 Business Overview
12.8.2 Financial Snapshot
12.8.2.1 Revenue by Segment
12.8.2.2 Revenue by Region
12.8.3 Products and Services
12.8.4 Recent Developments
12.9 QuidelOrtho Corporation
12.9.1 Business Overview
12.9.2 Financial Snapshot
12.9.2.1 Revenue by Segment
12.9.2.2 Revenue by Region
12.9.3 Products and Services
12.10 Sysmex Corporation
12.10.1 Business Overview
12.10.2 Financial Snapshot
12.10.2.1 Net Sales by Segment
12.10.2.2 Net Sales by Region
12.10.3 Products and Services

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us